Montelukast sodium
| Overview | |
| Catalog # | bs-82532c-50mg |
| Product Name | Montelukast sodium |
| Specifications | |
| Storage Buffer | Solid |
| Storage Condition | -20°C |
| Target | |
| Product Information | Potent, selective CysLT1 receptor (leukotriene D4) antagonist (Ki = 0.18 nM).1,2 Displays anti-inflammatory and anti-asthmatic effects. Clinically useful agent for treatment of chronic asthma.3 Attenuates chronic brain injury after focal cerebral ischemia in rodent models.4 Decreases blood brain barrier dysfunction in mouse models.5 Blockade of GPR17 by montelukast elevates neural stem and progenitor proliferation.6 |
| Description | CAS Number: 151767-02-1 Chemical Name: 2-[1-[[(1R)-1-[3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate, sodium salt Molecular weight: 608.17 Formula: C35H35ClNO3S Na Solubility: DMSO (60 mg/ml) Water (30 mg/ml) Ethanol (60 mg/ml) Physical Properties: Solid Purity: 98% by HPLC, NMR (Conforms) |
Frequently asked questions
Which applications is Montelukast sodium (bs-82532C) validated for, and at what dilution?
bs-82532C is validated for Life Science( N/A).
How should bs-82532C be stored?
-20°C Storage buffer: Solid